ADSTILADRIN: payments to doctors
Payments that named ADSTILADRIN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.6M
- Providers
- 5,542
- Transactions
- 18,370
- Average per transaction
- $140
The per-transaction average — $140 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,542 providers the average total is $465, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Ferring Pharmaceuticals Inc. | $2,467,003 | 95.7% |
| Ferring Pharmaceuticals AS | $88,535 | 3.4% |
| Ferring Pharmaceuticals Ltd. | $16,926 | 0.7% |
| Ferring Inc. | $4,340 | 0.2% |